Get the Stockscreener App
2.57
0.00%
0.00
After Hours:
2.45
-0.12
-4.67%
China Sxt Pharmaceuticals Inc stock is traded at $2.57, with a volume of 55,049.
It is up +0.00% in the last 24 hours and down -43.02% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$2.57
Open:
$2.6089
24h Volume:
55,049
Relative Volume:
0.37
Market Cap:
$35.37M
Revenue:
$1.93M
Net Income/Loss:
$-3.10M
P/E Ratio:
-0.157
EPS:
-16.3657
Net Cash Flow:
$-1.93M
1W Performance:
-7.22%
1M Performance:
-43.02%
6M Performance:
-59.64%
1Y Performance:
-81.43%
1-Day Range:
$2.41
$2.67
1-Week Range:
$2.41
$2.8822
52-Week Range:
$2.40
$26.96
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.57 | 35.37M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges - TipRanks
China SXT Pharmaceuticals regains compliance with Nasdaq’s minimum bid price deficiency - MSN
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange - TipRanks
China SXT Pharmaceuticals Regains Compliance With Nasdaq's Minimum Bid Price Requirement - Nasdaq
China SXT Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements - Nasdaq
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency - GlobeNewswire
China SXT Successfully Averts Nasdaq Delisting Through Strategic 1-for-8 Share Consolidation - StockTitan
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 1,448.9% in February - Defense World
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Stock market news: China SXT Pharmaceuticals plummented by 92.58% while Wah Fu Education Group skyrocketed by 78.37% during midday trading - Business Upturn
Stock market today: China SXT Pharmaceuticals -93.05%, Comstock -90.24% among biggest losers in early trading - Business Upturn
Stock market today: China SXT Pharmaceuticals plunged by 92.61% while Wah Fu Education Group surged by 239.75% in early trading - Business Upturn
SXTC stock touches 52-week high of $3.95 amid market fluctuations - Investing.com India
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
China SXT Pharmaceuticals announces 1-for-8 share consolidation - Investing.com
China SXT Pharmaceutics, Inc. Announces 1-for-8 Share Consolidation to Regain Nasdaq Compliance - Nasdaq
China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire
Will SXTC's Share Consolidation Save Its Nasdaq Listing? Key Dates Revealed - StockTitan
China SXT Pharmaceuticals Announces New Securities Purchase Agreement - MSN
China SXT Pharmaceuticals, Inc. announced that it expects to receive $2.84 million in funding - Marketscreener.com
China SXT Pharmaceuticals, Inc. Announces CEO Changes -January 23, 2025 at 04:15 pm EST - Marketscreener.com
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Before Buying China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock, Read This First - Stocks Register
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Up 1.5% – Should You Buy? - Defense World
SXTC stock hits 52-week low at $0.36 amid sharp annual decline - Investing.com
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
SXTC stock hits 52-week low at $0.37 amid sharp annual decline - Investing.com Australia
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals: Operational Risks and Profit Repatriation Challenges - TipRanks
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - markets.businessinsider.com
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule - Yahoo Finance
China SXT Pharma (NASDAQ: SXTC) to jump 2,500%a purely technical move - Dhaka Tribune
China SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5 - Nasdaq
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today? - InvestorPlace
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.06%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):